The Effect of Select Nutrients on Serum High-Density Lipoprotein Cholesterol and Apolipoprotein A-I Levels
The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Abstract
One of the factors contributing to the increased risk of developing premature atherosclerosis is low plasma concentrations of high-density lipoprotein (HDL) cholesterol (HDLc). Multiple potential mechanisms account for the cardioprotective effects of HDL and its main protein apolipoprotein A-I (apo A-I). The low plasma concentrations of HDL could be the result of increased fractional clearance and reduced expression of apo A-I. To this end, nutrients play an important role in modulating the fractional clearance rate, as well as the rate of apo A-I gene expression. Because medical nutrition therapy constitutes the cornerstone of management of dyslipidemias, it is essential to understand the mechanisms underlying the changes in HDL level in response to alterations in dietary intake. In this review, we will discuss the effect of select nutrients on serum HDLc and apo A-I levels. Specifically, we will review the literature on the effect of carbohydrates, fatty acids, and ketones, as well as some of the nutrient-related metabolites, such as glucosamine and the prostanoids, on apo A-I gene expression. Because there are multiple mechanisms involved in the regulation of serum HDLc levels, changes in gene transcription do not necessarily correlate with clinical observations on serum levels of HDLc.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moderate ethanol consumption (up to 20-30 g/day in men and 10-20 g/day in women) is associated with increased HDL-C levels as compared with abstainers.86”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [86]
Citations
Cites
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439 · cited 1×
“evidence in favor of therapeutic targeting of HDLc (12).”
BackgroundMensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 2×
“The reduced plasma apo A-I levels related to consumption of a low-fat diet are mostly attributed to increased fractional clearance of HDLc (3).”
BackgroundTurner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816 · cited 1×
“Some prostanoids are ligands of PPAR receptors (101, 102), and PPARs are implicated in the regulation of apo A-I expression (103, 104).”
BackgroundAtherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,701
Lee, J. Y., Sohn, K. H., Rhee, S. H., & Hwang, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011695200 · Cited by 1,299
HEALTH BENEFITS OF DOCOSAHEXAENOIC ACID (DHA)
HORROCKS, L. A., & YEO, Y. K. (1999) · Pharmacological Research · doi:10.1006/phrs.1999.0495 · Cited by 1,031
Fish consumption and the 30-year risk of fatal myocardial infarction
Daviglus, M. L., Stamler, J., Orencia, A. J., Dyer, A. R., Liu, K., Greenland, P., Walsh, M. K., Morris, D., & Shekelle, R. B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361502 · Cited by 902
Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.
Goodnight, S. H., Harris, W. S., Connor, W. E., & Illingworth, D. R. (1982) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.2.2.87 · Cited by 683
Reduced O Glycosylation of Sp1 Is Associated with Increased Proteasome Susceptibility
Han, I., & Kudlow, J. E. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2550 · Cited by 437
Overview of Proposed Mechanisms for the Hypocholesterolemic Effect of Soy
Potter, S. M. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.suppl_3.606s · Cited by 421
Overview of proposed mechanisms for the hypocholesterolemic effect of soy.
Potter, S. M. (1995) · PubMed · doi:10.1093/jn/125.3_suppl.606s · Cited by 384
Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by Pioglitazone
Sakamoto, J., Kimura, H., Moriyama, S., Odaka, H., Momose, Y., Sugiyama, Y., & Sawada, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3868 · Cited by 313
Vu-Dac, N., Chopin-Delannoy, S., Gervois, P., Bonnelye, E., Martin, G., Fruchart, J.-C., Laudet, V., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25713 · Cited by 297
Shah, P. K., Kaul, S., Nilsson, J., & Cercek, B. (2001) · Circulation · doi:10.1161/hc4501.098468 · Cited by 295
Claudel, T., Sturm, E., Duez, H., Torra, I. P., Sirvent, A., Kosykh, V., Fruchart, J.-C., Dallongeville, J., Hum, D. W., Kuipers, F., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14505 · Cited by 286
Aro, A., Jauhiainen, M., Partanen, R., Salminen, I., & Mutanen, M. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1419 · Cited by 281
Claudel, T., Sturm, E., Duez, H., Torra, I. P., Sirvent, A., Kosykh, V., Fruchart, J.-C., Dallongeville, J., Hum, D. W., Kuipers, F., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214505 · Cited by 279
n‐3 fatty acids and lipoproteins: Comparison of results from human and animal studies
Harris, W. S. (1996) · Lipids · doi:10.1007/bf02529870 · Cited by 264
Shepherd, J., Packard, C. J., Patsch, J. R., Gotto, A. M., & Taunton, O. D. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109385 · Cited by 248
Berthou, L., Duverger, N., Emmanuel, F., Langouët, S., Auwerx, J., Guillouzo, A., Fruchart, J. C., Rubin, E., Denèfle, P., Staels, B., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118687 · Cited by 248
Eriksson, M., Carlson, L. A., Miettinen, T. A., & Angelin, B. (1999) · Circulation · doi:10.1161/01.cir.100.6.594 · Cited by 228
O Glycosylation of an Sp1-Derived Peptide Blocks Known Sp1 Protein Interactions
Roos, M. D., Su, K., Baker, J. R., & Kudlow, J. E. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6472 · Cited by 223
Shah, P. K., Kaul, S., Nilsson, J., & Cercek, B. (2001) · Circulation · doi:10.1161/hc4401.098467 · Cited by 222
Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia.
Sanders, T. A., Sullivan, D. R., Reeve, J., & Thompson, G. R. (1985) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.5.5.459 · Cited by 212
Sekido, R., Murai, K., Funahashi, J., Kamachi, Y., Fujisawa-Sehara, A., Nabeshima, Y., & Kondoh, H. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.5692 · Cited by 211
de Roos, N. M., Bots, M. L., & Katan, M. B. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.092161 · Cited by 198
Cheung, M. C., Zhao, X.-Q., Chait, A., Albers, J. J., & Brown, B. G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0801.095151 · Cited by 190
O-GlcNAc and the control of gene expression
Comer, F. I., & Hart, G. W. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00176-2 · Cited by 184
Ordovas, J. M., Corella, D., Cupples, L. A., Demissie, S., Kelleher, A., Coltell, O., Wilson, P. W., Schaefer, E. J., & Tucker, K. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.1.38 · Cited by 182
Ginsberg, H. N. (1996) · Diabetes · doi:10.2337/diab.45.3.s27 · Cited by 168
Apolipoprotein A-II, HDL metabolism and atherosclerosis
Tailleux, A., Duriez, P., Fruchart, J., & Barthelemy-Clavey, V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00751-1 · Cited by 163
Cardiovascular Disease in Type 2 Diabetes Mellitus: Current Management Guidelines
Mooradian, A. D. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.33 · Cited by 159
Self-citationRole of Sp1 in insulin regulation of gene expression
Samson, S., & Wong, N. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0290265 · Cited by 159
Self-citationHDL: The Metabolism, Function, and Therapeutic Importance
Wang, M., & Briggs, M. R. (2004) · Chemical Reviews · doi:10.1021/cr020466v · Cited by 158
Coronary heart disease in seven countries
Keys, A. (1997) · Nutrition · doi:10.1016/s0899-9007(96)00410-8 · Cited by 154
Hayek, T., Ito, Y., Azrolan, N., Verdery, R. B., Aalto-Setälä, K., Walsh, A., & Breslow, J. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116375 · Cited by 149
Lefebvre, A.-M., Peinado-Onsurbe, J., Leitersdorf, I., Briggs, M. R., Paterniti, J. R., Fruchart, J.-C., Fievet, C., Auwerx, J., & Staels, B. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.9.1756 · Cited by 143
Perspective: Hexosamines and Nutrient Sensing
Rossetti, L. (2000) · Endocrinology · doi:10.1210/en.141.6.1922 · Cited by 139
Dietary cis and trans monounsaturated and saturated FA and plasma lipids and lipoproteins in men
Judd, J. T., Baer, D. J., Clevidence, B. A., Kris‐Etherton, P., Muesing, R. A., & Iwane, M. (2002) · Lipids · doi:10.1007/s11745-002-0871-9 · Cited by 132
Reiser, S., Powell, A. S., Scholfield, D. J., Panda, P., Ellwood, K. C., & Canary, J. J. (1989) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/49.5.832 · Cited by 131
Spady, D. K., Kearney, D. M., & Hobbs, H. H. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33380-0 · Cited by 126
Regulation of apo A-I gene expression by fibrates
Staels, B., & Auwerx, J. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00313-4 · Cited by 124
Sakai, T., Kamanna, V. S., & Kashyap, M. L. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1001.096624 · Cited by 123
Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol.
Auwerx, J., Bouillon, R., & Kesteloot, H. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.671 · Cited by 122
Effects of Glucose and Insulin on Rat Apolipoprotein A-I Gene Expression
Murao, K., Wada, Y., Nakamura, T., Taylor, A. H., Mooradian, A. D., & Wong, N. C. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18959 · Cited by 121
Self-citationBerthou, L., Saladin, R., Yaqoob, P., Branellec, D., Calder, P., Fruchart, J., Denèfle, P., Auwerx, J., & Staels, B. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20797.x · Cited by 119
Sorci‐Thomas, M. G., Prack, M. M., Dashti, N., Johnson, F., Rudel, L. L., & Williams, D. L. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38254-7 · Cited by 117
High-density lipoproteins and atherosclerosis
Rader, D. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02635-8 · Cited by 116
A hypothesis on the development of acute myocardial infarction in Greenlanders
Dyerberg, J., & Bang, H. O. (1982) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518209168395 · Cited by 116
Baer, D. J., Judd, J. T., Clevidence, B. A., Muesing, R. A., Campbell, W. S., Brown, E. D., & Taylor, P. R. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.3.593 · Cited by 115
Sastry, K., Seedorf, U., & Karathanasis, S. K. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.605 · Cited by 114
Rao, G. N., Katki, K. A., Madamanchi, N. R., Wu, Y., & Birrer, M. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.6003 · Cited by 108
A hypothesis on the development of acute myocardial infarction in Greenlanders
Dyerberg, J., & Bang, H. O. (1982) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365518209168395 · Cited by 100
Heikkinen, A., Tuppurainen, M., Niskanen, L., Komulainen, M., Penttila, I., & Saarikoski, S. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370495 · Cited by 99
Delerive, P., Galardi, C. M., Bisi, J. E., Nicodeme, E., & Goodwin, B. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0132 · Cited by 92
Temme, E. H. M., Mensink, R. P., & Hornstra, G. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37149-2 · Cited by 91
Hormonal regulation of apolipoprotein AI
Hargrove, G., Junco, A., & Wong, N. (1999) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0220103 · Cited by 90
Self-citationVessby, B. O., Boberg, J., Gustafsson, I., Karlström, B., Lithell, H., & Östlund‐Lindqvist, A. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90024-6 · Cited by 87
Craig, W. Y., Nutik, R., & Cooper, A. D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68326-7 · Cited by 86
Estrogen Regulation of the Apolipoprotein AI Gene Promoter through Transcription Cofactor Sharing
Harnish, D. C., Evans, M. J., Scicchitano, M. S., Bhat, R. A., & Karathanasis, S. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9270 · Cited by 83
Hennessy, L., Osada, J., Ordovas, J., Nicolosi, R., Stucchi, A., Brousseau, M., & Schaefer, E. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41525-1 · Cited by 80
TALMUD, P. J., HAWE, E., ROBERTSON, K., MILLER, G. J., MILLER, N. E., & HUMPHRIES, S. E. (2002) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2002.00105.x · Cited by 78
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
Wehmeier, K. R., Beers, A., Haas, M. J., Wong, N. C. W., Steinmeyer, A., Zügel, U., & Mooradian, A. D. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.09.004 · Cited by 76
Self-citationTalmud, P. J., Hawe, E., Robertson, K., et al. (2002) · PubMed · doi:10.1017/s0003480002001057 · Cited by 75
Wahrburg, U., Martin, H., Sandkamp, M., Schulte, H., & Assmann, G. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.4.678 · Cited by 73
Tovar‐Palacio, C., Potter, S. M., Hafermann, J. C., & Shay, N. F. (1998) · Journal of Nutrition · doi:10.1093/jn/128.5.839 · Cited by 73
Dussault, I., & FORMAN, B. M. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00071-x · Cited by 70
Insulin Induction of Apolipoprotein AI, Role of Sp1
Lam, J. K., Matsubara, S., Mihara, K., Zheng, X., Mooradian, A. D., & Wong, N. C. W. (2003) · Biochemistry · doi:10.1021/bi026984h · Cited by 69
Self-citationMen and Women Differ in Lipoprotein Response to Dietary Saturated Fat and Cholesterol Restriction
Li, Z., Lamon‐Fava, S., Velez‐Carrasco, W., Lichtenstein, A. H., McNamara, J. R., Ordovás, J. M., Schaefer, E. J., & Otvos, J. D. (2003) · Journal of Nutrition · doi:10.1093/jn/133.11.3428 · Cited by 67
Kagawa, A., Azuma, H., Akaike, M., Kanagawa, Y., & Matsumoto, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34111 · Cited by 65
The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes
Farvid, M. S., Siassi, F., Jalali, M., Hosseini, M., & Saadat, N. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.11.009 · Cited by 65
Srivastava, R. A. K., Srivastava, N., & Averna, M. R. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2000.01473.x · Cited by 65
Genetic analysis of apolipoprotein A-I in two dietary environments.
Blangero, J., MacCluer, J. W., Kammerer, C. M., Mott, G. E., Dyer, T. D., & McGill, H. C. (1990) · PubMed · Cited by 64
Azrolan, N., Odaka, H., Breslow, J. L., & Fisher, E. A. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19833 · Cited by 62
Nicolosi, R. J., Wilson, T. A., Rogers, E. J., & Kritchevsky, D. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32495-0 · Cited by 62
Walden, C. E., Retzlaff, B. M., Buck, B. L., Wallick, S., McCann, B. S., & Knopp, R. H. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1580 · Cited by 59
Zheng, X., Matsubara, S., Diao, C. T. M., Hollenberg, M. D., & Wong, N. C. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000621200 · Cited by 56
Self-citationClinical epidemiology of acute myocardial infarction
Tavazzi, L. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70320-0 · Cited by 55
Genistein Activates Apolipoprotein A-I Gene Expression in the Human Hepatoma Cell Line Hep G2
Lamon‐Fava, S. (2000) · Journal of Nutrition · doi:10.1093/jn/130.10.2489 · Cited by 53
Taylor, A. H., Wishart, P. M., Lawless, D., Raymond, J., & Wong, N. C. W. (1996) · Biochemistry · doi:10.1021/bi960269o · Cited by 52
Self-citationSrivastava, R. A. K., Tang, J., Krul, E. S., Pfleger, B. A., Kitchens, R. T., & Schonfeld, G. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90053-x · Cited by 52
Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: a stable isotope study
Frénais, R., Ouguerram, K., Maugeais, C., Marchini, J. S., Benlian, P., Bard, J. M., Magot, T., & Krempf, M. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33394-0 · Cited by 52
Osei, K., & Bossetti, B. (1989) · Diabetic Medicine · doi:10.1111/j.1464-5491.1989.tb01218.x · Cited by 50
Regulation of apoA-I gene expression
Lamon‐Fava, S., & Micherone, D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300179-jlr200 · Cited by 50
The Role of Thiazolidinediones in the Treatment of Patients with Type 2 Diabetes Mellitus
Mooradian, A. D., Chehade, J. M., & Thurman, J. E. (2002) · Treatments in Endocrinology · doi:10.2165/00024677-200201010-00002 · Cited by 48
Self-citationBuzzard, I. M., McRoberts, M. R., McRoberts, D., & Bowering, J. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.1.94 · Cited by 46
Romney, J. S., Chan, J., Carr, F. E., Mooradian, A. D., & Wong, N. C. W. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.6.1495493 · Cited by 45
Self-citationHigh-density lipoprotein metabolism: Molecular targets for new therapies for atherosclerosis
Kawashiri, M., Maugeais, C., & Rader, D. J. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0074-4 · Cited by 41
Hatahet, W., Cole, L. A., Fungwe, T. V., & Kudchodkar, B. J. (2003) · Journal of Nutrition · doi:10.1093/jn/133.3.689 · Cited by 40
Effect of Ethanol on Lipoprotein Secretion in Two Human Hepatoma Cell Lines, HepG2 and Hep3B
Tam, S. (1992) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1992.tb00693.x · Cited by 40
Jin, F.-Y., Kamanna, V. S., Chuang, M.-Y., Morgan, K., & Kashyap, M. L. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.8.1052 · Cited by 38
Shidfar, Keshavarz, Jallali, Miri, & Eshraghian (2003) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.73.3.163 · Cited by 37
Brousseau, M. E., Ordovás, J. M., Osada, J., Fasulo, J. M., Robins, S. J., Nicolosi, R. J., & Schaefer, E. J. (1995) · Journal of Nutrition · doi:10.1093/jn/125.3.425 · Cited by 37
Impact of hydrogenated fat on high density lipoprotein subfractions and metabolism
Lichtenstein, A. H., Jauhiainen, M., McGladdery, S. H., Ausman, L. M., Jalbert, S. M., Vilella-Bach, M., Ehnholm, C., Frohlich, J., & Schaefer, E. J. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31169-x · Cited by 37
Glucocorticoid increases rat apolipoprotein A-I promoter activity
Taylor, A. H., Raymond, J., Dionne, J. M., Romney, J. S., Chan, J., Lawless, D., Wanke, I. E., & Wong, N. C. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37304-1 · Cited by 37
Self-citationSakai, K., & Clemmons, D. R. (2003) · Endocrinology · doi:10.1210/en.2002-221133 · Cited by 35
Dashti, N., Feng, Q., & Franklin, F. A. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32359-2 · Cited by 34
In-vivo and in-vitro nutrient-gene interactions
Talmud, P. J., & Waterworth, D. M. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200002000-00005 · Cited by 33
Berthou, L., Staels, B., Saldicco, I., Berthelot, K., Casey, J., Fruchart, J., Denèfle, P., & Branellec, D. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1657 · Cited by 31
Zolfaghari, R., & Ross, A. C. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39945-4 · Cited by 31
Srivastava, R. A. K. (1994) · PubMed · Cited by 31
Functional changes of aorta with massive accumulation of calcium
Takeo, S., Anan, M., Fujioka, K., Kajihara, T., Hiraga, S., Miyake, K., Tanonaka, K., Minematsu, R., Mori, H., & Taniguchi, Y. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90079-8 · Cited by 30
Dietary oxidized fatty acids may enhance intestinal apolipoprotein A-I production
Rong, R., Ramachandran, S., Penumetcha, M., Khan, N., & Parthasarathy, S. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31485-1 · Cited by 30
Apolipoprotein A-I gene expression is regulated by cellular zinc status in Hep G2 cells
Wu, J. Y. J., Wu, Y., Reaves, S. K., Wang, Y. R., Lei, P. P., & Lei, K. Y. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.3.c537 · Cited by 29
Pharmacology of apolipoprotein A-l
Andersson, L. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199708000-00006 · Cited by 29
Wu, J. Y. J., Reaves, S. K., Wang, Y. R., Wu, Y., Lei, P. P., & Lei, K. Y. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.6.c1516 · Cited by 28
Transcriptional regulation of the apolipoprotein AI gene
Malik, S. (2003) · Frontiers in bioscience · doi:10.2741/1005 · Cited by 27
Johnson, G. E., & Obenshain, S. S. (1981) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.10.2088 · Cited by 27
Mooradian, A. D., Deebaj, L., & Wong, N. C. W. (1991) · Journal of Endocrinology · doi:10.1677/joe.0.1280079 · Cited by 27
Self-citationFrénais, R. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00723-1 · Cited by 27
Mooradian, A. D., & Albert, S. G. (1999) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(99)00007-x · Cited by 25
Self-citationInduction of the apolipoprotein AI promoter by Sp1 is repressed by saturated fatty acids
Haas, M. J., Horani, M. H., Wong, N. C. W., & Mooradian, A. D. (2004) · Metabolism · doi:10.1016/j.metabol.2004.05.011 · Cited by 25
Self-citationRegulation of apoA1 gene expression with acidosis: requirement for a transcriptional repressor
Haas, M., Reinacher, D., Li, J., Wong, N., & Mooradian, A. D. (2001) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0270043 · Cited by 25
Self-citationDietary Fat Saturation Affects Apolipoprotein AII Levels and HDL Composition in Postmenopausal Women
Sánchez-Muniz, F. J., Merinero, M. C., Rodríguez-Gil, S., Ordovás, J. M., de la Rocha, S. R., & Cuesta, C. (2002) · Journal of Nutrition · doi:10.1093/jn/132.1.50 · Cited by 24
Effects of Insulin and Glucose on Cultured Rat Hepatocyte Gene Expression
Mooradian, A. D., & Mariash, C. N. (1987) · Diabetes · doi:10.2337/diab.36.8.938 · Cited by 23
Self-citationWasner, H. K., Weber, S., Partke, H.-J., & Amini-Hadi-Kiashar, H. (1994) · Acta Diabetologica · doi:10.1007/bf00571947 · Cited by 22
Calleja, L., Trallero, M. C., Carrizosa, C., Méndez, M. T., Palacios−Alaiz, E., & Osada, J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00451-7 · Cited by 22
Vitamin A Regulates the Expression of Apolipoprotein Al and CIII Genes in the Rat
Nagasaki, A., Kikuchi, T., Kurata, K., Masushige, S., Hasegawa, T., & Kato, S. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2838 · Cited by 20
Apolipoprotein A1 expression in young and aged rats is modulated by dietary carbohydrates
Mooradian, A. D., Wong, N. C., & Shah, G. N. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90204-3 · Cited by 20
Self-citationBranchi, A., Rovellini, A., Tomella, C., Sciariada, L., Torri, A., Molgora, M., & Sommariva, D. (1997) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600408 · Cited by 20
Effect of sucrose diet on expression of apolipoprotein genes A-I, C-III and A-IV in rat liver
Peck‐Radosavljevic, M., Lin-Lee, Y.-C., Soyal, S. M., Strobl, W., Seelos, C., Gotto, A. M., & Patsch, W. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90018-c · Cited by 18
Haas, M., Pun, K., Reinacher, D., Wong, N., & Mooradian, A. D. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250129 · Cited by 18
Self-citationWahlberg, G., & Walldius, G. (1982) · Atherosclerosis · doi:10.1016/0021-9150(82)90029-6 · Cited by 17
Mooradian, A. D., Haas, M. J., & Wadud, K. (2006) · Metabolism · doi:10.1016/j.metabol.2005.08.008 · Cited by 17
Self-citationBerthou, L., Langouët, S., Grudé, P., Denèfle, P., Branellec, D., & Guillouzo, A. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00004-6 · Cited by 17
Hoogeveen, R. C., Reaves, S. K., & Lei, K. Y. (1995) · Journal of Nutrition · doi:10.1093/jn/125.12.2935 · Cited by 16
Huggins, K. W., Colvin, P. L., Burleson, E. R., Kelley, K. L., Sawyer, J. K., Barrett, P. H. R., Rudel, L. L., & Parks, J. S. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30279-0 · Cited by 16
Hexosamines as mediators of nutrient sensing: relevance to obesity, insulin resistance, and diabetes
McClain, D. A. (2001) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200108000-00004 · Cited by 14
Wu, J. Y. J., Zhang, J. J., Wang, Y., Reaves, S. K., Wang, Y. R., Lei, P. P., & Lei, K. Y. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.4.c1362 · Cited by 13
Effect of Chromium on Apolipoprotein A-I Expression in HepG2 Cells
Haas, M. J., Sawaf, R., Horani, M. H., Gobal, F. A., Wong, N. C. W., & Mooradian, A. D. (2003) · Nutrition · doi:10.1016/s0899-9007(02)00960-7 · Cited by 13
Self-citationHaas, M. J., Reinacher, D., Pun, K., Wong, N. C. W., & Mooradian, A. D. (2000) · Metabolism · doi:10.1053/meta.2000.18554 · Cited by 12
Self-citationZhang, J. J., Wang, Y., & Lei, K. Y. (1995) · Journal of Nutrition · doi:10.1093/jn/125.2.172 · Cited by 11
Effect of glucosamine on apolipoprotein AI mRNA stabilization and expression in HepG2 cells
Haas, M. J., Wong, N. C. W., & Mooradian, A. D. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.027 · Cited by 10
Self-citationSchwab, D. A., Rea, T. J., Hanselman, J. C., Bisgaier, C. L., Krause, B. R., & Pape, M. E. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00491-4 · Cited by 9
Sakai, T., Jin, F.-Y., Kamanna, V. S., & Kashyap, M. L. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00292-0 · Cited by 9
Apolipoprotein A-I Expression in Rats is Not Altered by Troglitazone 1
Mooradian, A. D., Haas, M. J., Chehade, J. M., & Wong, N. C. W. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222701108 · Cited by 8
Self-citationHorani, M. H., Gobal, F. A., Haas, M. J., Wong, N. C. W., & Mooradian, A. D. (2004) · Metabolism · doi:10.1016/j.metabol.2003.09.009 · Cited by 8
Self-citationIndomethacin inhibits endocytosis and degradation of insulin
Christensen, J. R., Hammond, B. J., & Smith, G. D. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81031-9 · Cited by 7
Research works printed but not linked: 2
- Romney, 1992, Identification of the thyroid hormone responsive mRNA-S11 as apolipoprotein A1 mRNA and the effects of the hormone on the promoter., Mol Endocrinol, 6, 943
- Mooradian, 2002, The role of thiazolidenediones in the treatment of type 2 diabetes., Treat Endocrinol, 1, 13, 10.2165/00024677-200201010-00002 · DOI
Cited by
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
Dyslipidemia in type 2 diabetes mellitus
Mooradian, A. D. (2009) · Nature Reviews Endocrinology · doi:10.1038/ncpendmet1066 · Cited by 1,042
Self-citationESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
An update on β-sitosterol: A potential herbal nutraceutical for diabetic management
Babu, S., & Jayaraman, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110702 · Cited by 658
Metadata
- Authors
- Mooradian, A. D., Haas, M. J., & Wong, N. C. W.
- Affiliations
- Saint Louis University (US)
- University of Calgary (CA)
- Corresponding author
- Mooradian, Arshag D.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2005-10-21
- Volume
- 27
- Issue
- 1
- Pages
- 2-16
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1970893501
- Cited by
- 91
- References
- 140
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 6 · 2013: 5 · 2012: 3
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
- Keywords
- HDL cholesterol, apolipoprotein A-I, dietary nutrients, carbohydrates, fatty acids, ketones, glucosamine, prostanoids, dyslipidemia, atherosclerosis, cardioprotection
- MeSH terms
- Animals, Cell Line, Diet, Dietary Carbohydrates, Dietary Fats, Fatty Acids, Gene Expression Regulation, Glucosamine, Humans, Ketones, Cholesterol, HDL, Prostaglandins, Transcription, Genetic, Apolipoprotein A-I, Nutrition Policy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.